Scarica l'app Stockscreener
1.12
13.69%
0.1349
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.9851
Aprire:
$0.98
Volume 24 ore:
196.56K
Relative Volume:
0.65
Capitalizzazione di mercato:
$10.20M
Reddito:
$9.19M
Utile/perdita netta:
$-6.94M
Rapporto P/E:
-1.3466
EPS:
-0.8317
Flusso di cassa netto:
$-7.57M
1 W Prestazione:
-15.79%
1M Prestazione:
-32.93%
6M Prestazione:
-76.52%
1 anno Prestazione:
-79.26%
Intervallo 1D:
$0.9746
$1.20
Intervallo di 1 settimana:
$0.9615
$1.34
Portata 52W:
$0.9615
$6.96
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Nome
Neuroone Medical Technologies Corp
Settore
Industria
Telefono
(952) 426-1383
Indirizzo
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.34 | 1.62B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.19 | 689.98M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
18.63 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.57 | 291.21M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
9.10 | 197.39M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-29 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Borsa (NMTC) Ultime notizie
NeuroOne Medical (NMTC) Expands Distribution in Southern Califor - GuruFocus
NeuroOne Medical (NMTC) Expands OneRF System Distribution in Sou - GuruFocus
Electric-shock facial pain gets a new treatment option in Southern California - Stock Titan
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement - Yahoo Finance
Neuroone Medical Technologies Corp (NMTC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan
Neuroone Medical Technologies Corp (NMTC) Peer Comparison – Compare with Others - Value Research
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
Neuroone Medical Technologies Corp (NASDAQ: NMTC) Stock Price, News & Analysis - kalkine.ca
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - Minichart
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform - Yahoo Finance
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
NeuroOne Medical (NMTC) Advances 6% to $1.94, Approaching Key ResistanceBollinger Expansion - dars.gov.et
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - Yahoo Finance
NeuroOne Medical Technologies Corp - tradingkey.com
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform - Yahoo Finance
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Cash Flow - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.900|Chg%:+0.050 - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.630|Chg%:+0.080 - TradingKey
AZIO Stock Price and Chart — NASDAQ:AZIO - tradingview.com
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial - Yahoo Finance
Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC) - Stock Titan
NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares - Stock Titan
Neuroone Medical Technologies Corp Azioni (NMTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neuroone Medical Technologies Corp Azioni (NMTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Market Development Director |
Jun 30 '26 |
Sale |
3.18 |
10,000 |
31,773 |
20,692 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):